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1. Introduction
   In 2012, it was estimated that about 35.3 (32.2–38.8) million 
people were living with HIV[1]. Currently, no therapy or vaccine 
is virucidal. However, it has been shown that the genetic 
makeup of each individual modifies his or her susceptibility to 
infection and subsequent progression to disease[2].
   Infection with HIV-1 results in a variety of clinical 
outcomes. There are individuals who remain uninfected 
despite multiple exposures to HIV-1. These uninfected 
persons include children born from HIV-1 seropositive 
mothers[3], sex workers in areas of high prevalence[4], 
and sexual partners of infected individuals[5]. Various 
genetic factors of the host have been associated with the 
protection against HIV-1 including variable genes HLA-B, 
HLA-C, CCR5 and CCL3L1[6-9]. A significant number of 
genes candidates can be selected to study the resistance 
to the HIV-1 infection and the progression towards the 
disease in serodiscordant couples. Our study focused on 
four molecules that play a role in the pathophysiological 
processes of HIV-1 infection: dendritic cell-specific 
ICAM3-grabbing non integrin (DC-SIGN, encoded by CD209), 
interferon regulatory factor 1 (IRF1), HLA-B57*01 and 
CCR5 delta 32 (CCR5Δ32). We studied 4 single nucleotide 
polymorphisms (SNPs) (2 SNPs of DC-SIGN promoter and 2 
SNPs of IRF1) and HLA-B57*01 allele and CCR5 32 base pairs 
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deletion in HIV-serodiscordant couples in Burkina Faso and 
their association with resistance to infection.
2. Materials and methods
2.1. Study site
   A cross-sectional study was conducted from March 2010 to 
April 2012 in Saint Camille Medical Centres of Ouagadougou 
and Nanoro, as well as in Pietro Annigoni Molecular 
Research Centre (CERBA) in Ouagadougou (Burkina Faso).
2.2. Inclusion criteria and sample collection
   HIV-1 serodiscordant couples having more than 4 years of 
married life before the beginning of the study and who gave 
their consent to participate were included in this study. The 
study involved 51 HIV-1 serodiscordant couples regularly 
monitored in the three centres. Blood of these participants 
were collected.
2.3. HIV serology
   Confirmation of HIV-1 positive status in serodiscordant 
couples was performed using Determine (Abbott, USA) and 
an ELISA (Bio-Rad, Marnes la Coquette, France).
2.4. DNA extraction and genotyping
   All DNA samples were extracted using the QIAGEN blood 
DNA extraction kit (QIAGEN, Hilden, Germany). DNA purities 
were estimated spectrophotometrically, and the final 
concentrations were determined by NanoDrop ND-1000. 
   CCR5Δ32 was genotyped by PCR as previously described 
by Veloso et al[10].
   For IRF1 genotyping, samples (10 ng of DNA) were 
genotyped by TaqMan assays (ABI, Applera International 
Inc, Foster City, CA, USA) in 20 µL reaction volume, using the 
ABI Fast 7500 real-time PCR systems. Fluorescence curves 
were analyzed with the 7500 Sequence Detection Software 
version 2.1 for allelic discrimination. 
   HLA-B57*01 genotype was done in all patients using 
the ABI Fast 7500 real-time PCR systems, in 20 µL reaction 
volume by Sacace assay (Sacace Biotechnologies, Como, 
Italy). All SNPs were selected based on physical location, 
assay availability and/or a previously reported association. 
   For DC-SIGN, samples (4 ng of DNA) were genotyped by 
TaqMan SNP assays (ABI, AppleraInternational Inc, Foster 
City, CA, USA) in 10 µL reaction volume, using the Rotor-
Gene 3000 (Corbett Robotics Pty Ltd, Brisbane, Queensland, 
Australia) and the ABI 7500 real-time PCR systems. 
Fluorescence curves were analyzed with the Rotor-Gene 
Software version 6 and the 7500 Sequence Detection Software 
version 1.2.1 for allelic discrimination.
2.5. Statistical analysis 
   Tests for deviation from Hardy-Weinberg equilibrium 
(HWE) were performed using Powermarker software[11]. 
   For other statistical analysis we used SAS 9.1 software 
(SAS Institute, Cary, NC, USA). For bivariate analysis we used 
Chi-square test, Fisher’s test and student’s t-test.
   For multivariate analysis, logistic regression (genotype 
association) and multiple linear (allele association) 
regression were also conducted in order to neutralize the 
confounding effect of sex.
2.6. Ethical approval
   The study was approved by the Joint CERBA/Saint Camille 
Ethics Committee. All participants signed a consent form 
prior to blood collection. 
3. Results
3.1. Sociodemographic factors of the serodiscordant couples 
   The study population consisted of 51 serodiscordant 
couples. The mean time of exposure to HIV-1 was (6.1依2.8) 
years in serodiscordant couples and the annual average 
of sexual intercourse was 68. The mean age of the study 
population was higher in HIV-1 negative than in HIV-1 
positive (43.3依8.8 v.s. 38.9依7.8, P<0.01). The prevalence 
of HIV-1 was significantly higher in women compared to 
men (P<0.001) and in housewives (P<0.001) than in other 
occupations (Table 1).
Table 1 
Sociodemographic characteristics of HIV-1 serodiscordant couples.
Sociodemographic characteristics Frequency of 
HIV positive 
(n=51)
Frequency of 
HIV negative
 (n=51)
P value
Sex Male 0.24 0.76 <0.001
Female 0.76 0.24
Education Illiterate 0.51 0.49 NS
Koranic school 0.00 1.00
Primary school 0.57 0.43
Secondary school 0.45 0.55
University 0.50 0.50
Occupation Traders 0.31 0.69 <0.001
Farmers 0.56 0.44
Government 
employees
0.27 0.73
Housewives 0.74 0.26
Use of condom before HIV testing Yes 0.63 0.37 NS
Use of condom after HIV testing Yes 0.51 0.49 NS
NS: Not significant.
3.2. Polymorphisms of CCR5Δ32, DC-SIGN, IRF1 and HLA-
B57*01
   CCR5Δ32 polymorphism showed that 100% of the 
serodiscordant couples carried homozygote wild type alleles.
   Two SNPs located in the DC-SIGN promoter region and 
separated by 197 base pairs (rs4804803 and rs2287886) were 
analyzed. The IRF1 gene was also investigated for two SNPs 
(rs10213701 and rs10065633) respectively localized in an intron 
and in the 3’-untranslated region (Table 2). 
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Table 2
Information by locus tested in serodiscordant women.
Gene Marker Chromosome position Function Allele
DC-SIGN Chr. 
19q13.2
rs4804803 (-336) 7718733 Promoter A/G
rs2287886 (-139) 7718536 Promoter A/G
IRF1 Chr. 5q31.1 rs10065633 131844615 3’ Downstream C/T
rs10213701 131851963 Intronic T/A
   All DC-SIGN and IRF1 SNPs typed were in HWE. The SNP of 
the promoter DC-SIGN -336 (rs4804803) showed a genotypic 
difference between HIV positive and negative individuals (P 
=0.048). The conditions of validity did not allow us to perform 
a test for DC-SIGN -139 (rs2287886) (Table 3).
   The DC-SIGN -139G allele was significantly more frequent 
among HIV-1 negative (81%) compared to positive individuals 
(67%) (P=0.025), but after correction for the gender 
confounding effect this difference was no longer significant 
(Table 3). Also, in an additive model (AA v.s. GG & AG), DC-
SIGN -139G allele was associated with protection against 
HIV-1 in serodiscordant couples (P<0.001). This association 
remained significant even after integrating gender as a 
confounding variable in a logistic regression (P <0.01).
   The two IRF1 SNPs typed did not show any significant 
association at allelic and genotypic levels in HIV-1 
serodiscordant couples.
   We found a high frequency of HLA-B57*01 allele in the 
HIV-positive (78%) compared to HIV-negative subjects (51%) 
(P=0.004) but this difference was no longer significant after 
adjusting for the gender confounding effect in a logistic 
regression model (P=0.16) (Table 3).
4. Discussion
   This study investigated host genetic factors associated with 
resistance to HIV-1 in serodiscordant couples in Burkina Faso.
   The duration of exposure to HIV-1 in serodiscordant couples 
(6.1 years) and the annual average of sexual intercourse (68) 
reported in this study are consistent with standards defined 
by World Health Organization.
   The high prevalence of HIV-1 in women (76%) found in 
the present report is in accordance with the phenomenon of 
feminization of HIV-1 reported in previous studies[12,13].
   In previous study, it has been shown that HLA-B57*01 
allele was associated with HIV resistance in Africans highly 
exposed and in African serodiscordant couples[14-16]; here 
we report a high prevalence of HLA-B57*01 allele in HIV-1 
positive compared to HIV-negative individuals. However, the 
association between HLA-B57*01 and HIV-1 infection was no 
longer significant in serodiscordant couples after adjustment 
for the confounding effect of sex.
   The absence of mutation in the CCR5Δ32 gene in 
serodiscordant couples in Burkina Faso confirms the results 
of previous studies that have shown that this deletion of 32 
base pairs is rare in populations of African origin[17].
   Regarding the role of variants of DC-SIGN promoter in 
protection against HIV-1, we found no association at the 
allelic and genotypic levels variants between DC-SIGN -336 
and DC-SIGN -139 and protection against HIV-1. Only a DC-
SIGN -139G allele was associated with protection against 
HIV-1 in an additive model in serodiscordant couples. Our 
Table 3
Genetic factors and HIV status among serodiscordant couples.
Gene Frequency of HIV 
negative (n=51)
Frequency of HIV 
positive (n=51)
OR (95% CI) P value Adjusted OR (95% CI) *Adjusted P value
CCR5Δ32 (wt/wt) 1.00 1.00
HLA-B57*01 0.51  0.78 3.50 (1.50-8.30)  0.004 2.10 (0.70-5.70)  0.16
DC-SIGN rs4804803 AA 0.17 0.39  
AG 0.63 0.43   0.048
GG 0.20 0.18
GG+AG 0.83 0.61     0.33 (0.10-0.80)** <0.001    0.33 (0.20-1.20)**  0.10
Frequency G 0.51 0.39   0.150  0.25
HWE 0.50 0.07
rs2287886 AA 0.00 0.16   
AG 0.37 0.35  0.012
GG 0.63 0.49
GG+AG 1.00 0.84 0.05 (0.03-0.90) <0.001 0.33 (0.10-1.20) <0.01
Frequency G 0.81 0.67   0.025   0.13
HWE 0.14 0.10
IRF1 rs1006533 CC 0.35 0.35   
CT 0.45 0.49   0.860
TT 0.20 0.16
TT+CT 0.65 0.65 1.00 (0.44-2.20)   1.000 0.59 (0.22-1.58)  0.29
Frequency T 0.42 0.40   0.090  0.49
HWE 0.59 0.89
rs10213701 AA 0.10 0.22   
AT 0.49 0.39   0.240
TT 0.41 0.39
TT+AT 0.90 0.78 0.40 (0.12-1.20)   0.100 0.40 (0.10-1.10)  0.21
Frequency T 0.66 0.59   0.330  0.71
HWE 0.53 0.17
wt: Wild type; OR: Odds ratio; CI: Confidence interval; *: P-value adjusted by logistic regression (logit);  **: Fischer test.
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results are consistent with those of a previous study which 
has shown an association between -139G allele and protection 
against HIV-1 infection[18]. No association was found between 
the -336G allele and the susceptibility to HIV-1 as previously 
reported by Martin et al[18].
   The two IRF1 SNPs (rs1006533 and rs10213701) tested in our 
study did not reveal any significant association with HIV-1 
infection in serodiscordant couples. In contrast, Ball et al. 
using two other SNPs A619C and G6516T showed an association 
between IRF1 gene polymorphism and resistance to HIV-1 
infection in a cohort of Kenyan women sex workers[19].
   We report for the first time the protective effect of a variant 
in the promoter of DC-SIGN against HIV-1 infection in 
serodiscordant couples in Burkina Faso, suggesting a genetic 
resistance allele. Other associations reported in previous 
studies especially with DC-SIGN -336G and HLA-B57*01 
alleles or with CCR5Δ32 were not found. This could be 
explained by the genetic differences between the two study 
populations investigated: Caucasian and African.
   Our results should be confirmed in a larger cohort. They 
show the growing evidence that genetic mechanisms may 
confer resistance to HIV-1 infection through multiple and 
complex pathways. 
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